Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
- 16 June 2006
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 13 (10) , 701-707
- https://doi.org/10.1111/j.1365-2893.2006.00750.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Multicenter Evaluation of the Performance Characteristics of the Bayer VERSANT HCV RNA 3.0 Assay (bDNA)Journal of Clinical Microbiology, 2004
- 192 Early viral kinetics prediction of sustained virological response after 1 or 4 weeks of PEG-interferon-ALFA-2A and ribavirin therapy (Ditto-HCV project)Hepatology, 2003
- Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis CHepatology, 2003
- Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During TherapyHepatology, 2003
- Monitoring of viral levels during therapy of hepatitis CHepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatmentAmerican Journal of Gastroenterology, 2001
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C*1Hepatology, 1995
- Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis CGastroenterology, 1995